The Role of Human Urotensin-II in Patients with Hypertrophic Cardiomyopathy.
CONCLUSION: Results of the first study indicated that serum hUT-II levels were markedly elevated in patients with HCM. Serum hUT-II is a novel biomarker parameter that has clinical use in patients with the severity of LVH.
PMID: 28686108 [PubMed - as supplied by publisher]
Source: Journal of Immunoassay and Immunochemistry - Category: Biochemistry Tags: J Immunoassay Immunochem Source Type: research
More News: Biochemistry | Cardiology | Cardiomyopathy | Cardiovascular | Genetics | Heart | Hormones | Hypertrophic Cardiomyopathy | Laboratory Medicine | Study